China Investment Corporation (CIC) has teamed up with France-based GP Eurazeo and BNP Paribas to launch a Europe-China growth fund with a target corpus of EUR1-1.5 billion ($1.1-1.7 billion).
According to a release, all three partners will invest significantly in the fund and pursue additional LP commitments. Eurazeo, which has a team of eight professionals in China, will act as fund manager,...
China-based data storage software services provider XSKY has raised a RMB320 million ($45 million) Series D led by China's State Owned Capital Venture Capital Fund.
CF PharmTech, a Chinese medical devices maker focused on innovative respiratory products, has raised a $50 million Series F round with support from CICC Capital.
Chinese insulin manufacturer Gan & Lee Pharmaceuticals, which counts Qiming Venture Partners and Goldman Sachs among its investors, raised RMB2.5 billion ($354 million) through an A-share IPO.
KKR has agreed to buy a 54% stake in Indian drug maker J.B. Chemicals & Pharmaceuticals for INR31.1 billion ($416 million) and made an open offer for an additional 26% of the company.